Cargando…
Treatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function
Coronavirus disease 2019, the disease caused by the severe acute respiratory syndrome coronavirus 2 virus, was first identified in the Hubei Province of China in late 2019. Currently, the only role for therapy is treatment of the disease, as opposed to postexposure prophylaxis, however multiple clin...
Autores principales: | Miller-Handley, Hilary, Luckett, Keith, Govil, Amit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the National Kidney Foundation, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498223/ https://www.ncbi.nlm.nih.gov/pubmed/33308510 http://dx.doi.org/10.1053/j.ackd.2020.09.001 |
Ejemplares similares
-
Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021) -
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
por: McCreary, Erin K, et al.
Publicado: (2020) -
Tranexamic Acid: A Potential Treatment Option for Coronavirus Disease 2019
por: Chan, Kok Hoe, et al.
Publicado: (2020) -
Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea
por: Jeon, Jaehyun, et al.
Publicado: (2022) -
Diagnostic options for coronavirus disease 2019 (COVID-19)
por: Xiao, Yuanyuan, et al.
Publicado: (2020)